Home/Filings/4/0001181431-12-064079
4//SEC Filing

Abdalian Charles H Jr 4

Accession 0001181431-12-064079

CIK 0001407038other

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 4:22 PM ET

Size

5.2 KB

Accession

0001181431-12-064079

Insider Transaction Report

Form 4
Period: 2012-12-10
Abdalian Charles H Jr
EVP & Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2012-12-10+140,000140,000 total
    Exercise: $1.33Exp: 2022-12-10Common Stock (140,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 25% of the shares on October 18, 2013 and vests as to an additional 6.25% of the shares per quarter thereafter until October 18, 2016.

Issuer

BG Medicine, Inc.

CIK 0001407038

Entity typeother

Related Parties

1
  • filerCIK 0001335290

Filing Metadata

Form type
4
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 4:22 PM ET
Size
5.2 KB